Our new website is coming soon, give it a try now and let us have your feedback. Take me to the Beta



Register
Login:
Share:
Email Facebook Twitter


TSX Lithium explorer International Lithium Corp prepares to drill at Raleigh Lake
Exclusive: Hardman & Co Investor Forum - Severn Trent, Calculus Capital, Volta Finance, Residential




Share Price Information for Scancell Holdings (SCLP)


Share Price: 6.75Bid: 6.50Ask: 7.00Change: 0.00 (0.00%)No Movement on Scancell Hldgs
Spread: 0.50Spread as %: 7.69%Open: 6.75High: 6.75Low: 6.75Yesterday’s Close: 6.75

Scancell Holdings Plc Ord 0.1P

Scancell Holdings is listed in the FTSE AIM All-Share
Scancell Holdings is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
6.75
Share Price SpacerBid
6.50
Share Price SpacerAsk
7.00
Share Price SpacerChange
0%0.00
Share Price SpacerVolume
60,000
Share Price SpacerOpen
6.75
Share Price SpacerHigh
6.75
Share Price SpacerLow
6.75
Share Price SpacerClose
6.75
Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 465.36m £31.41m 20,000

52 Week High 13.50 52 Week High Date 20-SEP-2018
52 Week Low 3.70 52 Week Low Date 9-MAY-2019

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
1 0 60,000 -5.037 -1.34 0.00 0.00


London South East Users info for Scancell Holdings




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

24-Jun-19
08:12:27
6.77
60,000
Buy* 
6.50
7.00
4,062
Trade Type:
Ordinary

21-Jun-19
15:43:07
6.50
22,000
Sell* 
6.50
7.00
1,430
Trade Type:
Ordinary

21-Jun-19
15:43:07
6.50
22,000
Sell* 
6.50
7.00
1,430
Trade Type:
Ordinary




View more Scancell Holdings trades >>

Directors Deals for Scancell Holdings (SCLP)
Trade DateActionNotifierPriceCurrencyAmountHolding
11-May-17Placing
Trade Notifier Information for Scancell Holdings
John Chiplin held the position of Non-Executive Director at Scancell Holdings at the time of this trade.
 John Chiplin
10GBX1,041,1771100000
10-Dec-13Notification of Holding
Trade Notifier Information for Scancell Holdings
Lindy Durrant held the position of CEO at Scancell Holdings at the time of this trade.
 Lindy Durrant
000
10-Dec-13Notification of Holding
Trade Notifier Information for Scancell Holdings
Richard Goodfellow held the position of Joint CEO at Scancell Holdings at the time of this trade.
 Richard Goodfellow
000
View more Scancell Holdings directors dealings >>


CHELSEA7
Posts: 36,358
Premium Chat Member
Opinion:Strong Buy
Price:6.75
H/L Dummy Sell
Today 08:14
Will take 60k at 6.555

Opened at 30k at 6.52
CHELSEA7
Posts: 36,358
Premium Chat Member
Opinion:No Opinion
Price:6.75
SP
Today 08:12
Off to a decent start
CHELSEA7
Posts: 36,358
Premium Chat Member
Opinion:Strong Buy
Price:6.75
Morning All
Today 05:03
Another one of those long nights, really odd, from sleeping 18 hours a day, been lucky to get an hours sleep here and there these past few weeks. And one thing for sure it is not Scancell that is to blame for that, far from it.............

For me today heralds in the beginning of another new period in our development and growth as a company. The first for me was the period where David Evans was reading the agenda of the AGM, the first one I attended must be back in 2013 in London now. I could say the second period began after he finished, lol, it went on for ages, it was painful, but the second period for me was when John Chiplin replaced Evans, and for all the criticism he has taken from so many, we have under him arrived at the third phase, with the addition of Vulpes to our share holders and IMHO a very impressive Martin Diggle as we move back into human trials.

I don"t think it takes too much imagination to look back in retrospect, and see the mess we were in when he joined the BOD, and I will always remember LD and RG at a Derby AGM trying to reassure us all that relationships between the BOD had never been stronger. So easy looking at everything in retrospect, and in doing so the timelines make sense now as to a large degree does the fall in the SP.

So in the next few days we begin the SCIB1/Keytruda trial, knowing that MOD1 is getting nearer every day to its early 2020 start, and SCIB2 under the competent guidance of CRUK behind that and hopefully a start by a further 6 month period. Are there many companies recently valued at just under £20m who will have three important trials running at the same time, not to mention the next candidates progress to trials, the Glycans/Mabs etc etc.?? I rather doubt it.

So lets have a good week and enjoy this share, it has been a long time coming.
CHELSEA7
Posts: 36,358
Premium Chat Member
Opinion:No Opinion
Price:6.75
RE: C7
Sun 22:58
Hi, I had a problem posting it too. Speak soon buddy, and keep punching.
Wassatt
Posts: 81,778
Opinion:No Opinion
Price:6.75
C7
Sun 22:50
Thanks m8, really appreciate it, but just now I can't access much at all, I keep on getting skeleton man up
View more share chat for Scancell Holdings (SCLP) >>







Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk









Home  |  Contact Us  |  About Us  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy  |  Mobile Site  |  About this website design


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.